BioSenic S.A. (BIOS) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.052x

Based on the latest financial reports, BioSenic S.A. (BIOS) has a cash flow conversion efficiency ratio of 0.052x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.39 Million ≈ $-1.62 Million USD) by net assets (€-26.81 Million ≈ $-31.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BioSenic S.A. (BIOS) defensive interval to measure how many days the company can operate on defensive assets alone.

BioSenic S.A. - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how BioSenic S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

BioSenic S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioSenic S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
MEP Infrastructure Developers Limited NSE:MEP	-0.376x
Fitness Champs Holdings Limited Common Stock NASDAQ:FCHL	0.100x
Prosper Gold Corp. V:PGX	-0.028x
New Energy Metals Corp V:ENRG	-0.053x
Lypsa Gems & Jewellery Limited NSE:LYPSAGEMS	0.052x
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	-0.008x
Oncternal Therapeutics Inc NASDAQ:ONCT	-0.760x
Golden Cross Resources Ltd AU:GCR	-0.046x

Annual Cash Flow Conversion Efficiency for BioSenic S.A. (2012–2024)

The table below shows the annual cash flow conversion efficiency of BioSenic S.A. from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of BioSenic S.A..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-26.81 Million ≈ $-31.34 Million	€-2.23 Million ≈ $-2.61 Million	0.083x	-45.50%
2023-12-31	€-22.70 Million ≈ $-26.54 Million	€-3.47 Million ≈ $-4.06 Million	0.153x	+125.00%
2022-12-31	€3.12 Million ≈ $3.65 Million	€-1.91 Million ≈ $-2.23 Million	-0.611x	-132.35%
2021-12-31	€-6.76 Million ≈ $-7.91 Million	€-12.78 Million ≈ $-14.95 Million	1.890x	+139.07%
2020-12-31	€3.33 Million ≈ $3.89 Million	€-16.08 Million ≈ $-18.80 Million	-4.837x	+4.75%
2019-12-31	€2.05 Million ≈ $2.39 Million	€-10.40 Million ≈ $-12.16 Million	-5.078x	-76.78%
2018-12-31	€4.49 Million ≈ $5.25 Million	€-12.90 Million ≈ $-15.08 Million	-2.873x	+37.87%
2017-12-31	€2.38 Million ≈ $2.79 Million	€-11.02 Million ≈ $-12.88 Million	-4.624x	-521.01%
2016-12-31	€15.27 Million ≈ $17.85 Million	€-11.37 Million ≈ $-13.29 Million	-0.745x	-78.12%
2015-12-31	€28.15 Million ≈ $32.91 Million	€-11.77 Million ≈ $-13.75 Million	-0.418x	-212.50%
2014-12-31	€-9.48 Million ≈ $-11.09 Million	€-3.52 Million ≈ $-4.12 Million	0.372x	+100.71%
2013-12-31	€63.00K ≈ $73.65K	€-3.27 Million ≈ $-3.83 Million	-51.968x	-3284.99%
2012-12-31	€2.64 Million ≈ $3.08 Million	€-4.05 Million ≈ $-4.73 Million	-1.535x	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#30182 Global

#111 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66